Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in ...

Eli Lilly dominates obesity and diabetes treatments with soaring tirzepatide sales and promising oral drug data. Find out why ...

Eli Lilly hires former FDA official Rachel Anatol to lead global regulatory strategy in genetic medicine. Read more here.

Lila Biologics, a spinoff from Nobel Laureate David Baker’s research at the University of Washington, is collaborating with ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative ...

Tribeca Studios has launched a new incubator program, which aims to empower rising filmmakers to more earnestly portray diseases and health-related stories on-screen. Tribeca created the program in ...

We recently compiled a list of the 10 High Growth Pharma Stocks That Are Profitable in 2025. Eli Lilly and Company is one of them. Eli Lilly and Company (NYSE:LLY) tops our list for being one of the ...

The restructuring, which would eliminate 11% of the company's workforce, aimed to reduce organizational complexity and speed ...

Lilly, which sells the Alzheimer’s drug Kisunla, has recruited Moore to its global “Brain Health Matters” campaign. Drawing ...

Novo Nordisk will cut 9,000 jobs in a global restructuring, targeting annual savings of $1.26 billion, as it faces ...

A 7-year landmark analysis also showed sustained benefits in invasive disease-free survival/IDFS and distant relapse-free ...